Role of β-catenin expression in paediatric mesenchymal lesions: A tissue microarraybased immunohistochemical study

European Journal of Histochemistry

Volumn 56, Issue 3, 2012, Pages 157-163

  Santoro, A ^a   Pannone, G ^a   Errico, M E ^b   Bifano, D ^b   Lastilla, G ^c   Bufo, P ^a   Loreto Dr , C ^d   Donofrio, V ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Paediatric Oncological Hospital Pausillipon   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Beta catenin; Immunohistochemistry; Paediatric mesenchymal tumours; Wnt pathway

Indexed keywords

EID: 84863793831     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2012.e25     Document Type: Article

References (40)

1. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008;8:387-398.
2. Miller JR. The Wnts. Genome Biol 2001;3:reviews3001.1-3001.15.
3. Brown JD, Moon RT. Wnt signaling: why is everything so negative? Curr Opin Cell Biol 1998;10:182-187.
4. Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene 2000;19:537-545.
5. Miller JR, Hocking AM, Brown JD, Moon RT. Mechanism and function of signal transduction by the Wnt/Beta-catenin and Wnt/Ca+2 pathways. Oncogene 1999;18:7860-7872.
6. Novak A, Dedhar S. Signaling through Beta- catenin and Lef/Tcf. Cell Mol Life Sci 1999;56:523-537.
7. Nusse R. Wnt signaling and stem cell control. Cell Res 2008;18:523-527.
8. Bakre MM, Hoi A, Mong JC, Koh YY, Wong KY, Stanton LW. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. J Biol Chem 2007; 282:31703-31712.
9. Woll PS, Morris JK, Painschab MS, Marcus RK, Kohn AD, Biechele TL, Moon RT, Kaufman DS. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008;111:122-131.
10. Harington KJ, Syrigos KN. The role of ECadherin- Catenin complex: more than an intercellular glue? Ann Surgic Oncol 2000; 7:783-788.
11. Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002;26:463-476.
12. Clevers H and Bienz M. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-320.
13. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
14. Hasegawa T, Yokoyama R, Matsuno Y, Shimoda T, Hirohashi S. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol 2001;32:257-263.
15. Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al. Nuclear betacatenin in mesenchymal tumors. Mod Pathol 2005;18:68-74.
16. Bain G, Müller T, Wang X, Papkoff J. Activated Beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participated in BMP2 mediated signal transduction. Biochem Biophys Res Commun 2003;301:84-91.
17. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998;153:709-714.
18. Giarola M, Wells D, Mondini P, Pilotti S, Sala P, Azzarelli A, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 1998;78:582-587.
19. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151:329-334.
20. Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998;10:591-594.
21. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, et al. Predominance of betacatenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615-6620.
22. De Wever I, Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology. Mod Pathol 2000;13:1080-1085.
23. Couture J, Mitri A, Lagace R, Smits R, Berk T, Bouchard HL, et al. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of betacatenin in the desmoid tumor. Clin Genet 2000;57:205-212.
24. Shitoh K, Konishi F, Iijima T, Ohdaira T, Sakai K, Kanazawa K, et al. A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene. J Clin Pathol 1999;52:695-696.
25. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-381.
26. Klaus A, Birchmeier W. Wnt signaling and its impact on development and cancer. Nat Rev Cancer 2008;8:387-398.
27. Hoover BA, Muschler G. Beta-catenin mediated Wnt signaling as a marker for characterization of human bone marrow-derived connective tissue progenitor. The Journal of Young Investigators 2005;12. Available from: http://www.jyi.org/research/re.php?id=190
28. Gebert C, Hardes J, Kersting C, August C, Supper H, Winkelmann W, et al. Expression of b-catenin and p53 are prognostic factors in deep aggressive fibromatosis. Histopathol 2007;50:491-497.
29. Lazar AJF, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, et al. Tumorigenesis and Neoplastic Progression. Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors. Am J Pathol 2008;173:1518-1527.
30. Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 2002;26:1296-1301.
31. Thway, K and Gibson, S and Ramsay, A, Sebire, NJ. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases. Pediatr Devel Pathol 2009;12:292-296.
32. Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol 2001;14:695-701.
33. Saito T, Oda Y, Sakamoto A, Tamiya S, Kinukawa N, Hayashi K, et al. Prognostic value of the preserved expression of the Ecadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma. J Pathol 2000;192: 342-350.
34. Haydon RC, Deyrup A, Ishikawa A, Heck R, Jiang W, Zhou L, et al. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer 2002;102:338-342.
35. Sakamoto A, Oda Y, Adachi T, Saito T, Tamiya S, Iwamoto Y, et al. Beta-catenin dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med 2002;126:1071-10478.
36. Kuhnen C, Herter P, Muller O, Muehlberger T, Krause L, Homann H, et al. Beta-catenin in soft-tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol 2000;13:1005-1013.
37. Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol 1995;19:979-993.
38. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653-659.
39. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Mini- Review. Epithelial-mesenchymal and mesenchymal- epithelial transitions in carcinoma progression. J Cell Physiol 2007;213: 374-383.
40. Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, et al. β-Catenin and TGF β signalling cooperate to maintain a mesenchymal phenotype after FosERinduced epithelial to mesenchymal transition. Oncogene 2004;23:2672-2680.